Studies Reveal How Plant-Based Diets Influence Gut Health and Metabolism

Recent research led by Jenna AbuSalim and Joshua Rabinowitz at Ludwig Princeton offers new insights into the relationship between plant-based diets and gut health. Published in the Proceedings of the National Academy of Sciences and Nature Metabolism, these studies examine how dietary components impact gut bacteria and subsequent metabolic health.

The first study found that plant fiber and specific plant proteins, referred to as “proteins imitating fiber” or Prif, can modify microbial metabolism to enhance the production of beneficial metabolites while reducing harmful ones. This is crucial as a diverse gut bacteria population is linked to improved health outcomes across various systems, including the immune and cardiovascular systems.

“There’s growing interest across medical disciplines in manipulating the human microbiome or using its metabolic products themselves for therapy,” noted Rabinowitz. “Diet holds great promise for controlling the microbiome and its outputs.” However, he stressed the necessity of understanding how particular dietary components influence microbial outputs to devise effective therapeutic strategies.

Influencing Phenol Metabolites

The PNAS study revealed how plant-based foods affect the production of phenol metabolites—compounds synthesized by gut bacteria when processing amino acids like tyrosine and phenylalanine. Beneficial metabolites such as phenylpropionate and hippuric acid are linked to gut health, while harmful ones like p-cresol sulfate are associated with negative health outcomes in cancer patients and those with kidney disease.

AbuSalim explained that the research demonstrated how both fiber and Prif can shift the balance of phenol metabolites from harmful to beneficial types. Fiber decreases the bacterial breakdown of the gut’s mucus lining, while Prif increases the intake of dietary proteins conducive to producing helpful phenols.

Examining Metabolite Origins

The Nature Metabolism study investigated not just phenol metabolites but also indole metabolites, produced from the amino acid tryptophan. These compounds have been linked to various diseases, including inflammatory bowel disease and cancer. Traditionally, it was believed that these metabolites originated solely from gut bacteria.

Employing isotope tracing methods across mice, rats, and human cells, the researchers found that mammalian metabolism could independently produce many of these metabolites, such as indole-3-lactate and indole-3-acetate. Notably, metabolite levels remained elevated in subjects after antibiotics disrupted their microbiomes, contrasting with the decline of microbially produced metabolites.

These findings could reshape therapeutic approaches aimed at elevating or lowering specific metabolites through diet. Understanding how various foods influence microbial production will enhance dietary recommendations for disease prevention and treatment, Rabinowitz concluded. The studies were funded by the Ludwig Institute for Cancer Research, the National Institutes of Health, and other organizations affiliated with Princeton University.